Gas Top denied as not FDA-approved for this use by Aetna?
Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for gas top are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on Gas Top
## Why Aetna Denied a Gastric Balloon as Not FDA-Approved
A "not FDA-approved" denial can arise in two distinct situations: (1) Aetna's records show the specific device model prescribed does not carry FDA clearance or approval for the intended use, or (2) there has been a documentation or coding error in the prior authorization submission that caused the reviewer to believe the prescribed device lacks FDA status. It can also arise if the procedure is being requested for an indication outside the device's cleared labeling.
This denial is critically important to verify against the actual FDA status of the specific device prescribed — because if the device is in fact FDA-cleared, the denial is factually incorrect and directly appealable on that basis.
## Your Federal Appeal Rights
- Internal appeal (ACA §2719 / ERISA §503): You have the right to full-and-fair internal review. If FDA clearance exists, the appeal should be a straightforward correction of a factual error.
- External review: If the internal appeal fails, escalate to IRO review within approximately four months of the final internal denial. An IRO reviewer will independently assess FDA status.
- Expedited review: Available if clinical urgency applies; typically resolved within 72 hours of request.
## Building a Strong Appeal
### Documentation to Gather
1. FDA clearance documentation: Verify with your prescribing physician or the device manufacturer that the specific balloon device prescribed carries FDA 510(k) clearance or PMA approval. Obtain the clearance letter or the FDA device listing number (K-number or PMA number) and include it in your appeal. 2. Intended use confirmation: Confirm that the device is being prescribed for an indication that falls within its FDA-cleared labeling. Ask your prescriber to state this explicitly in writing. 3. Prescription/order documentation: Ensure the device name, manufacturer, and model number on the prescription exactly match the FDA-cleared product. Transcription errors in PA submissions are a common cause of this denial type. 4. Prescriber letter: Should confirm FDA clearance status, the specific cleared indication, and that the prescription matches the cleared device. 5. Aetna's coverage policy: Review whether Aetna's policy requires a specific type of FDA authorization (clearance vs. approval) and confirm the device satisfies that requirement.
### Criteria-Mapping Structure
This appeal is more fact-correction than criteria-mapping. Structure your appeal letter as: (1) Aetna's stated basis for denial, (2) the documented FDA status of the device (with clearance number), (3) confirmation that the intended use matches the cleared indication, and (4) a request that Aetna reverse the denial based on the corrected factual record.
## Key Message to Your Prescriber
If the device is FDA-cleared, this denial should be among the most straightforward to overturn — provided the documentation is precise. The prescriber letter should include the device name, the FDA clearance number, the cleared indication, and a statement that the prescription is for that cleared indication. Vague statements about FDA status will not be sufficient; reviewers need a specific, verifiable reference.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →